What is the target serum thyroid-stimulating hormone (TSH) level during pregnancy?

TSH Goals in Pregnancy

For pregnant women with hypothyroidism, the goal is to normalize TSH levels to within pregnancy-specific reference ranges: ≤2.5 mIU/L in the first trimester and ≤3.0 mIU/L in the second and third trimesters. 1

Treatment Targets by Clinical Scenario

Hypothyroidism in Pregnancy

• Women with established hypothyroidism should be treated with levothyroxine in sufficient dosage to return TSH to normal levels 1
• The target is TSH ≤2.5 mIU/L during the first trimester and ≤3.0 mIU/L during subsequent trimesters 2, 3
• TSH should be monitored every 4 weeks until stable, then checked every trimester 1
• More than 50% of women with pre-existing hypothyroidism require a 30% increase in levothyroxine dose when pregnancy is confirmed 3

Preconception Optimization for Women with Hashimoto Thyroiditis

• Women with Hashimoto thyroiditis require lower preconception TSH targets than the gestational goals to prevent first-trimester thyroid insufficiency 4
• For hypothyroid women on levothyroxine, preconception TSH should be ≤1.24 mIU/L to ensure first-trimester TSH remains ≤2.5 mIU/L 4
• For euthyroid women with Hashimoto thyroiditis not on treatment, preconception TSH should be ≤1.73 mIU/L to maintain first-trimester TSH ≤2.5 mIU/L 4
• These preconception targets are approximately 50% lower for treated patients and 30% lower for untreated patients compared to the gestational target 4

Hyperthyroidism in Pregnancy

• For women with Graves' disease treated with thioamides, the goal is to maintain free T4 (FT4) or free thyroxine index (FTI) in the high-normal range using the lowest possible thioamide dosage 1
• TSH is typically suppressed in hyperthyroidism, so FT4/FTI monitoring every 2-4 weeks is more clinically useful than TSH monitoring 1

Important Caveats and Population-Specific Considerations

Reference Range Variability

• The commonly cited 2.5 mIU/L cutoff for first trimester may be too stringent for some populations 5
• Recent evidence suggests the 97.5th percentile of TSH at end of first trimester is between 3.0-4.0 mIU/L depending on analytical method, ethnicity, and iodine nutrition 5
• For low-risk North Indian women with adequate iodine, an upper limit of 4.5 mIU/L was appropriate 6
• Population-specific reference ranges should be considered when available, rather than applying a universal 2.5 mIU/L cutoff 6, 5

Initial Levothyroxine Dosing

When hypothyroidism is newly discovered during pregnancy, appropriate initial levothyroxine doses are:

• 1.20 μg/kg/day for subclinical hypothyroidism with TSH ≤4.2 mIU/L 2
• 1.42 μg/kg/day for subclinical hypothyroidism with TSH >4.2-10 mIU/L 2
• 2.33 μg/kg/day for overt hypothyroidism 2
• Using these weight-based doses, 89% of subclinical and 77% of overt hypothyroidism patients achieved target TSH with initial dosing alone, avoiding delays from dose titration 2

Common Pitfalls to Avoid

• Do not delay treatment initiation while waiting for additional testing in overt hypothyroidism—euthyroidism should be attained as soon as possible 2, 3
• Do not use non-pregnancy-specific reference ranges—TSH normally decreases in early pregnancy due to hCG cross-reactivity 5
• Do not assume pre-pregnancy levothyroxine doses are adequate—most women require dose increases during pregnancy 3
• Do not overlook hyperemesis gravidarum as a cause of biochemical hyperthyroidism (suppressed TSH)—this typically requires no treatment 1